Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis

(2010) Yoshihide Asano et al.   AMERICAN JOURNAL OF PATHOLOGY

Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension

(2010) Revathi Rajkumar et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts

(2010) G. Farina et al.   ANNALS OF THE RHEUMATIC DISEASES

Type I interferon system activation and association with disease manifestations in systemic sclerosis

(2010) M.-L. Eloranta et al.   ANNALS OF THE RHEUMATIC DISEASES

A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis

(2010) G. Farina et al.   ARTHRITIS AND RHEUMATISM

Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis

(2010) Minoru Hasegawa et al.   CLINICAL RHEUMATOLOGY

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

(2010) Timothy R D J Radstake et al.   NATURE GENETICS

Polymorphisms inTBX21andSTAT4increase the risk of systemic sclerosis: Evidence of possible gene–gene interaction and alterations in Th1/Th2 cytokines

(2009) Pravitt Gourh et al.   ARTHRITIS AND RHEUMATISM

Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis

(2009) P. Dieudé et al.   ARTHRITIS AND RHEUMATISM

Innate immunity and inflammation in systemic sclerosis

(2009) Robert Lafyatis et al.   CURRENT OPINION IN RHEUMATOLOGY

CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis

(2009) Mirko Moreno Zaldivar et al.   HEPATOLOGY

The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype

(2009) B. Rueda et al.   HUMAN MOLECULAR GENETICS

The Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis

(2009) Suzanne Holewijn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression

(2009) Timothy R. D. J. Radstake et al.   PLoS One

Induction of interferon‐α by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon‐α activity with lung fibrosis

(2008) Daniel Kim et al.   ARTHRITIS AND RHEUMATISM

The innate immune system in SLE: type I interferons and dendritic cells

(2008) L Rönnblom et al.   LUPUS

The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis

(2008) Sallouha Aidoudi et al.   PLoS One

The Immunobiology of Systemic Sclerosis

(2008) Y. Stephanie Gu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study

(2007) A. Antonelli et al.   RHEUMATOLOGY